GFA
8783
Chiome Bioscience
4583
Pluszero
5132
Pixel
2743
GreenBee
3913
(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (Q4)Mar 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 3.39%13.61B | -4.65%10.57B | -3.68%11.09B | 15.32%45.53B | -0.67%9.77B | 13.03%13.17B | 30.03%11.09B | 21.50%11.51B | 96.98%39.48B | 72.59%9.83B |
Cost of revenue | 0.09%4.54B | -8.28%3.57B | -7.94%3.72B | 15.23%15.84B | -1.72%3.37B | 14.98%4.54B | 29.42%3.89B | 20.15%4.04B | 89.19%13.75B | 61.00%3.43B |
Gross profit | 5.12%9.07B | -2.69%7.01B | -1.39%7.37B | 15.37%29.69B | -0.13%6.39B | 12.05%8.63B | 30.33%7.2B | 22.26%7.47B | 101.41%25.74B | 79.57%6.4B |
Operating expense | 4.67%6.5B | 9.10%6.55B | 9.12%6.42B | 10.00%26.01B | 30.26%7.92B | 6.86%6.21B | 4.40%6B | -2.10%5.88B | -1.35%23.65B | 1.72%6.08B |
Operating profit | 6.29%2.57B | -61.67%460M | -40.25%950M | 76.12%3.68B | -573.60%-1.53B | 28.03%2.42B | 638.12%1.2B | 1,428.85%1.59B | 118.68%2.09B | 113.36%322M |
Net non-operating interest income (expenses) | -13.76%-124M | -12.96%-122M | -11.32%-118M | -8.33%-429M | -1.92%-106M | -10.10%-109M | -14.89%-108M | -7.07%-106M | -6.74%-396M | -13.04%-104M |
Non-operating interest income | --0 | --0 | --0 | 0.00%1M | --0 | --1M | --0 | --0 | -50.00%1M | --0 |
Non-operating interest expense | 12.73%124M | 12.96%122M | 11.32%118M | 8.31%430M | 1.92%106M | 11.11%110M | 13.68%108M | 7.07%106M | 6.43%397M | 13.04%104M |
Net investment income | ||||||||||
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -13,000.00%-129M | 0 | -116.80%-42M | -249.82%-412M | 39.97%-790M | -99.89%1M | -52.08%127M | -43.69%250M | 108.85%275M | -91.84%-1.32B |
Less:Other special charges | ---- | ---- | ---- | 85.05%-293M | 121.14%85M | 99.89%-1M | 47.08%-127M | 42.79%-250M | -415.11%-1.96B | -87.85%-402M |
Less:Write off | --129M | --0 | --42M | -58.16%705M | -58.96%705M | --0 | --0 | --0 | -32.17%1.69B | 90.89%1.72B |
Other non-operating income (expenses) | -500.00%-42M | 0.00%3M | 1,800.00%38M | 39.68%-76M | -1,580.00%-74M | 80.56%-7M | 0.00%3M | 102.04%2M | -48.24%-126M | 104.55%5M |
Income before tax | -1.22%2.27B | -71.93%343M | -52.42%826M | 50.05%2.76B | -127.23%-2.5B | -12.74%2.3B | 2,593.88%1.22B | 393.18%1.74B | 111.62%1.84B | 66.73%-1.1B |
Income tax | 33.74%868M | -74.45%104M | 119.67%320M | -3,740.00%-1.34B | -168.40%-773M | 64.30%649M | 466.67%407M | -5,148.39%-1.63B | -108.03%-35M | -19.01%-288M |
Net income | -14.89%1.41B | -70.67%239M | -84.98%505M | 118.86%4.11B | -112.86%-1.72B | -26.28%1.65B | 1,214.52%815M | 778.07%3.36B | 111.53%1.88B | 73.54%-809M |
Net income continuous operations | -14.95%1.41B | -70.67%239M | -84.95%506M | 118.86%4.11B | -112.59%-1.72B | -26.32%1.65B | 1,214.52%815M | 778.07%3.36B | 111.53%1.88B | 73.51%-810M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -14.89%1.41B | -70.67%239M | -84.98%505M | 118.86%4.11B | -112.86%-1.72B | -26.28%1.65B | 1,214.52%815M | 778.07%3.36B | 111.58%1.88B | 73.54%-809M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -14.89%1.41B | -70.67%239M | -84.98%505M | 118.86%4.11B | -112.86%-1.72B | -26.28%1.65B | 1,214.52%815M | 778.07%3.36B | 111.58%1.88B | 73.54%-809M |
Gross dividend payment | ||||||||||
Basic earnings per share | -24.25%93.41 | -77.31%13.34 | -87.56%31.76 | 133.35%300.77 | -105.94%-136.68 | -26.98%123.31 | 7,247.50%58.78 | 897.50%255.36 | 110.31%128.89 | 71.85%-66.37 |
Diluted earnings per share | -35.85%79.1 | -77.31%13.34 | -84.94%28.52 | 118.75%231.26 | -105.94%-136.68 | -26.98%123.31 | 7,247.50%58.78 | 777.17%189.38 | 108.45%105.72 | 71.86%-66.37 |
Dividend per share | 0 | 10 | 0 | 20 | 20 | 0 | 0 | 0 | 0 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |